☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
J&J acquired global co-development and Commercialization rights of experimental myeloma gene therapy from a Chinese Start-up N...
August 6, 2018
Bluebird bio and Regeneron Announce R&D and Commercialization Collaboration for Novel Cancer Immune Cell Therapies
August 6, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions